A-443654, an AKT pathway inhibitor, suppresses tumor growth by inducing apoptosis and may further sensitize NSCLC cells to ferroptosis through metabolic reprogramming and inhibition of survival signaling (81–83). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.